These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients. Puig JM; Lloveras J; Fernández-Crespo P; Mir M; Iñigo V; Manresa JM; Masramón J Transplant Proc; 1999 Sep; 31(6):2259-60. PubMed ID: 10500567 [No Abstract] [Full Text] [Related]
3. Mycophenolate mofetil, ATG, and cyclosporine in the induction treatment of renal transplant recipients minimizes the incidence of acute rejection episodes. Puig JM; Lloveras J; Fernández-Crespo P; Mir M; Marcas LI; Manresa JM; Masramón J Transplant Proc; 1998 Aug; 30(5):2226-7. PubMed ID: 9723449 [No Abstract] [Full Text] [Related]
4. Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine. Fabrega AJ; Corwin CL; Hunsicker L Transplant Proc; 1998 Jun; 30(4):1562-3. PubMed ID: 9636634 [No Abstract] [Full Text] [Related]
5. Drug fever caused by mycophenolate mofetil in a renal transplant recipient--a case report. Chueh SC; Hong JC; Huang CY; Lai MK Transplant Proc; 2000 Nov; 32(7):1925-6. PubMed ID: 11120003 [No Abstract] [Full Text] [Related]
6. Lymphocyte subsets in renal transplant recipients treated with mycophenolate mofetil. François M; Büchler M; Halimi JM; Al-Najjar A; Valentin JF; Thibault G; Lebranchu Y Transplant Proc; 2000 Dec; 32(8):2781-2. PubMed ID: 11134803 [No Abstract] [Full Text] [Related]
7. Prospective study of mycophenolate mofetil for the prevention of acute rejection in living donor renal allograft recipients. Park K; Kim SI; Moon JI; Kim YS; Kim MS Transplant Proc; 1998 Nov; 30(7):3575. PubMed ID: 9838565 [No Abstract] [Full Text] [Related]
8. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Sollinger HW Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033 [TBL] [Abstract][Full Text] [Related]
9. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group. Forsythe J Transplant Proc; 1999 Nov; 31(7A):69S-71S. PubMed ID: 10576049 [No Abstract] [Full Text] [Related]
13. Mycophenolate mofetil (Cellcept) in renal transplantation: the European experience. The European Mycophenolate Mofetil Co-operative Study Group. Carl S; Wiesel M Transplant Proc; 1997 Nov; 29(7):2932-5. PubMed ID: 9365619 [No Abstract] [Full Text] [Related]
14. Tolerance of mycophenolate mofetil is dependent on kidney function. Puggia R; Rizzolo M; Maresca MC; Calconi G; Vianello A Transplant Proc; 1998 Aug; 30(5):2228. PubMed ID: 9723450 [No Abstract] [Full Text] [Related]
16. Role of immunosuppressive drugs in the development of tissue-invasive cytomegalovirus infection in renal transplant recipients. Kuypers DR; Evenepoel P; Maes BD; Coosemans W; Pirenne J; Vanrenterghem YF Transplant Proc; 2002 Jun; 34(4):1164-70. PubMed ID: 12072305 [No Abstract] [Full Text] [Related]
17. Tacrolimus/mycophenolate mofetil vs cyclosporine A/Azathioprine after simultaneous pancreas and kidney transplantation: five-year results of a randomized study. Woeste G; Wullstein C; Dette K; Pridöhl O; Lübke P; Bechstein WO Transplant Proc; 2002 Aug; 34(5):1920-1. PubMed ID: 12176629 [No Abstract] [Full Text] [Related]
18. [Mycophenolate mofetil in comparison with other immunosuppressive drugs]. Schnülle P; van der Woude FJ Internist (Berl); 1998 Aug; 39(8):879-86. PubMed ID: 9757398 [No Abstract] [Full Text] [Related]
19. Comparison of the safety and efficacy of mycophenolate mofetil, prednisolone and cyclosporine and conventional cyclosporine and prednisolone in kidney transplantation. Kim HC; Park SB; Kim HT; Cho WH; Park CH Transplant Proc; 2000 Nov; 32(7):1751-2. PubMed ID: 11119919 [No Abstract] [Full Text] [Related]
20. Mycophenolate mofetil improves long-term graft survival following renal transplantation in patients experiencing delayed graft function. International Mycophenolate Mofetil Renal Study Groups. Cho S; Hodge E; Navarro M Transplant Proc; 1999; 31(1-2):322-3. PubMed ID: 10083126 [No Abstract] [Full Text] [Related] [Next] [New Search]